SynthesisCell and tissue banking2025
Efficacy of Platelet and Leukocyte Rich Fibrin (L-PRF) in the healing process and bone repair in maxillary sinus lift surgeries: a systematic review.
Synthesis in Cell and tissue banking, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sinus lift surgery is essential after pneumatization caused by loss of posterior teeth. Leukocyte-Platelet-Rich Fibrin (L-PRF) accelerates bone healing by releasing growth factors that promote angiogenesis, cell differentiation, and inflammatory modulation. To evaluate the efficacy of L-PRF in bone healing and repair in sinus lift surgeries, in addition to investigating its role in angiogenesis and inflammatory modulation. The systematic review protocol included definition of the research question, search strategy, inclusion and exclusion criteria, study types, effect measures, screening methods, and data analysis. The search resulted in 860 studies. After removal of duplicates, 704 articles remained, of which 11 met the inclusion criteria. After careful evaluation, 4 studies were considered highly relevant and included in the systematic review. Evidence indicates that the combination of L-PRF with bone grafts, such as DBBM, can accelerate bone formation and allow early implant placement, supported by increased expression of protein markers essential for osteogenesis. The addition of L-PRF to DBBM demonstrated significant benefits in promoting a more favorable bone environment, reducing the time required for osseointegration.
Indexed as
Identifiers
40856870What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.